4 completed. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 3 | 1 | Completed 1 |
Follow Graves' Disease: new trials by email Literature Review of Graves' Disease trials Research Report on Graves' Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease CFZ533 - Graves' Disease | Phase 2 | Completed | Novartis Pharmaceuticals | 15 | 2016-04-19 | 2021-01-05 |
| Early Levothyroxine Post Radioactive Iodine Levothyroxine, Placebo - Graves' Disease | Phase 2 / Phase 3 | Completed | Mayo Clinic | 61 | 2013-09-01 | 2019-10-29 |
| Radioactive Iodide Therapy for Pediatric Graves' Disease RAI treatment, ATD Group - Graves' Disease | Phase 2 | Completed | University of Florida | 19 | 2010-10-01 | 2017-11-06 |
| rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter Recombinant human thyrotropin (Thyrogen) - Benign Nontoxic and Toxic Goiter, Graves' Disease | Phase 2 | Completed | Odense University Hospital | 110 | 2002-04-01 | 2010-12-28 |
Graves Disease (4) · Hyperthyroidism (2) · Hypothyroidism (1) · Neoplasms (1) · Patient Satisfaction (1)
Autoimmune Diseases (4) · Endocrine System Diseases (4) · Exophthalmos (4) · Eye Diseases (4) · Goiter (4) · Immune System Diseases (4) · Orbital Diseases (4) · Thyroid Diseases (4) · Hyperthyroidism (2) · Behavior (1) · Health Behavior (1) · Treatment Adherence and Compliance (1)
Thyroid Hormones (1) · Thyrotropin Alfa (1) · Thyroxine (1) · iscalimab (1)
Mayo Clinic (1) · Novartis Pharmaceuticals (1) · Odense University Hospital (1) · University of Florida (1)
United States (3) · Denmark (1) · Germany (1)
Marius Stan, MD (1) · Scott A Rivkees, MD (1) · Viveque Egsgaard Nielsen, MD (1)
PMID 16864757, PMID 31512728, PMID 34149627
2015 (1)